Embryonic stem cells ameliorate piroxicam-induced colitis in IL10-/- KO mice

Biochemical and Biophysical Research Communications

Volumn 361, Issue 4, 2007, Pages 953-959

  Srivastava, Anand S ^a   Feng, Zhongling ^b   Mishra, Rangnath ^c   Malhotra, Rakesh ^d   Kim, Hyun S ^b   Carrier, Ewa ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

CD; Crohn's disease; ES cell therapy; ES cells

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; PIROXICAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL MIGRATION; COLITIS; COLON; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROHN DISEASE; EMBRYONIC STEM CELL; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; IN VITRO STUDY; INTESTINE EPITHELIUM; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; SPLEEN; THYMUS;

ANIMALS; COLITIS; COLON; CROHN DISEASE; EMBRYONIC STEM CELLS; INTERLEUKIN-10; MICE; MICE, KNOCKOUT; PIROXICAM;

MURINAE; MUS;

EID: 34547890333     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.139     Document Type: Article

References (38)

1. Glogri Crohn B. A pathological and clinical entity. J. Am. Med. Assoc. 99 (1923) 1323-1329
2. Brynskov J., and Tvede N. Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease, effect of cyclosporin. Gut. 31 (1990) 795-799
3. Rogler G., and Andus T. Cytokines in inflammatory bowel disease. World J. Surg. 22 (1998) 382-389
4. Scheinin T., Butler D.M., Salway F., Scallon B., and Feldmann M. Validation of the interleukin-10 knockout mouse model of colitis: antitumour necrosis factor-antibodies suppress the progression of colitis. Clin. Exp. Immunol. 133 (2003) 38-43
5. Sartor R.B. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 106 (1994) 533-539
6. Elson C.O., Sartor R.B., Tennyson G.S., and Riddell R.H. Experimental models of inflammatory bowel disease. Gastroenterology 109 (1995) 1344-1367
7. Blumberg R.S., Saubermann L.J., and Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol. 11 (1999) 648-656
8. Leach M.W., Bean A.G., Mauze S., Coffman R.L., and Powrie F. Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells. Am. J. Pathol. 148 (1996) 1503-1515
9. MacDonald T.T. Gastrointestinal inflammation. Inflammatory bowel disease in knockout mice. Curr. Biol. 4 (1994) 261-263
10. Rennick D.M., Fort M.M., and Davidson N.J. Studies with IL-10-/- mice: an overview. J. Leukoc. Biol. 61 (1997) 389-396
11. Braegger C.P., Nicholls S., Murch S.H., Stephens S., and MacDonald T.T. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 339 (1992) 89-91
12. Lukacs N.W., Chensue S.W., Strieter R.M., Warmington K., and Kunkel S.L. Inflammatory granuloma formation is mediated by TNF-alpha-inducible intercellular adhesion molecule-1. J. Immunol. 152 (1994) 5883-5889
13. van Dullemen H.M., van Deventer S.J., Hommes D.W., Bijl H.A., Jansen J., Tytgat G.N., and Woody J. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109 (1995) 129-135
14. Targan S.R., Hanauer S.B., van Deventer S.J., Mayer L., Present D.H., Braakman T., DeWoody K.L., Schaible T.F., and Rutgeerts P.J. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N. Engl. J. Med. 337 (1997) 1029-1035
15. Present D.H., Rutgeerts P., Targan S., Hanauer S.B., Mayer L., van Hogezand R.A., Podolsky D.K., Sands B.E., Braakman T., DeWoody K.L., Schaible T.F., and van Deventer S.J. Infliximab for the treatment of fistulas in patients with Crohn's disease. N. Engl. J. Med. 340 (1999) 1398-1405
16. Powrie F., Leach M.W., Mauze S., Menon S., Caddle L.B., and Coffman R.L. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1 (1994) 553-562
17. Sher A., Fiorentino D., Caspar P., Pearce E., and Mosmann T. Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J. Immunol. 147 (1991) 2713-2716
18. O'Garra A., Chang R., Go N., Hastings R., Haughton G., and Howard M. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22 (1992) 711-717
19. Mosmann T.R. Cytokine secretion patterns and cross-regulation of T cell subsets. Immunol. Res. 10 (1991) 183-188
20. de Waal M.R., Haanen J., Spits H., Roncarolo M.G., te V.A., Figdor C., Johnson K., Kastelein R., Yssel H., and de Vries J.E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174 (1991) 915-924
21. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
22. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84 (1994) 4008-4027
23. Magram J., Connaughton S.E., Warrier R.R., Carvajal D.M., Wu C.Y., Ferrante J., Stewart C., Sarmiento U., Faherty D.A., and Gately M.K. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4 (1996) 471-481
24. Davidson N.J., Hudak S.A., Lesley R.E., Menon S., Leach M.W., and Rennick D.M. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J. Immunol. 161 (1998) 3143-3149
25. Duchmann R., Schmitt E., Knolle P., Meyer zum Buschenfelde K.H., and Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 26 (1996) 934-938
26. Neurath M.F., Fuss I., Kelsall B.L., Stuber E., and Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182 (1995) 1281-1290
27. Ehrhardt R.O., Ludviksson B.R., Gray B., Neurath M., and Strober W. Induction and prevention of colonic inflammation in IL-2-deficient mice. J. Immunol. 158 (1997) 566-573
28. Sellon R.K., Tonkonogy S., Schultz M., Dieleman L.A., Grenther W., Balish E., Rennick D.M., and Sartor R.B. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66 (1998) 5224-5231
29. Feng Z., Srivastava A.S., Mishra R., and Carrier E. A regulatory role of Wnt signaling pathway in the hematopoietic differentiation of murine embryonic stem cells. Biochem. Biophys. Res. Commun. 324 (2004) 1333-1339
30. Hermiston M.L., Wong M.H., and Gordon J.I. Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. Genes Dev. 10 (1996) 985-996
31. Ho A.S., and Moore K.W. Interleukin-10 and its receptor. Ther. Immunol. 1 (1994) 173-185
32. Leonard J.P., Waldburger K.E., and Goldman S.J. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181 (1995) 381-386
33. Yokoi H., Kato K., Kezuka T., Sakai J., Usui M., Yagita H., and Okumura K. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12. Eur. J. Immunol. 27 (1997) 641-646
34. Murphy E.E., Terres G., Macatonia S.E., Hsieh C.S., Mattson J., Lanier L., Wysocka M., Trinchieri G., Murphy K., and O'Garra A. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180 (1994) 223-231
35. Kennedy M.K., Picha K.S., Shanebeck K.D., Anderson D.M., and Grabstein K.H. Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones. Eur. J. Immunol. 24 (1994) 2271-2278
36. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., and Hattori K. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 (1995) 88-91
37. Takeda K., Tsutsui H., Yoshimoto T., Adachi O., Yoshida N., Kishimoto T., Okamura H., Nakanishi K., and Akira S. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8 (1998) 383-390
38. Pape K.A., Khoruts A., Mondino A., and Jenkins M.K. Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells. J. Immunol. 159 (1997) 591-598